137 related articles for article (PubMed ID: 23432984)
1. The potential role of APOBEC3G in limiting replication of hepatitis B virus.
Mohamadkhani A; Pourdadash A; Tayebi S; Estakhri A; Nazem H; Sotoudeh M; Poustchi H
Arab J Gastroenterol; 2012 Dec; 13(4):170-3. PubMed ID: 23432984
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of the relationship between hepatitis B virus precore and basal core promoter mutations and acute-on-chronic liver failure].
Ma XY; Han T; Pei YZ; Zhao ZG; Gao YT; Li Y; Jing L
Zhonghua Gan Zang Bing Za Zhi; 2012 Sep; 20(9):644-8. PubMed ID: 23207226
[TBL] [Abstract][Full Text] [Related]
3. Pre-core/basal-core promoter and reverse transcriptase mutations in chronic HBV infected-patients.
Xu L; Chen EQ; Lei J; Liu L; Zhou TY; Gao Z; Tang H
Hepatogastroenterology; 2012; 59(113):212-5. PubMed ID: 22251541
[TBL] [Abstract][Full Text] [Related]
4. Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India.
Chauhan R; Kazim SN; Bhattacharjee J; Sakhuja P; Sarin SK
J Med Virol; 2006 Aug; 78(8):1047-54. PubMed ID: 16789012
[TBL] [Abstract][Full Text] [Related]
5. Compound IMB-Z inhibits hepatitis B virus replication through increasing APOBEC3G expression and incorporation into viral nucleocapsids.
Hu J; Wang H; Yang L; Wu S; Li Y; Li Y; Li Z
J Glob Antimicrob Resist; 2022 Dec; 31():371-378. PubMed ID: 36396043
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C.
Baumert TF; Rösler C; Malim MH; von Weizsäcker F
Hepatology; 2007 Sep; 46(3):682-9. PubMed ID: 17625792
[TBL] [Abstract][Full Text] [Related]
7. Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen-positive chronic hepatitis B.
Sonneveld MJ; Rijckborst V; Zeuzem S; Heathcote EJ; Simon K; Senturk H; Pas SD; Hansen BE; Janssen HL
Hepatology; 2012 Jul; 56(1):67-75. PubMed ID: 22307831
[TBL] [Abstract][Full Text] [Related]
8. Genetic variability in the precore and core promoter regions of hepatitis B virus strains in Karachi.
Abbas Z; Muzaffar R; Siddiqui A; Naqvi SA; Rizvi SA
BMC Gastroenterol; 2006 Jul; 6():20. PubMed ID: 16863587
[TBL] [Abstract][Full Text] [Related]
9. Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.
Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander R; Patterson AP
J Biol Chem; 2017 Aug; 292(32):13459-13479. PubMed ID: 28637869
[TBL] [Abstract][Full Text] [Related]
10. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).
He X; Li J; Wu J; Zhang M; Gao P
Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702
[TBL] [Abstract][Full Text] [Related]
11. Analysis of HBV genotype, drug resistant mutations, and pre-core/basal core promoter mutations in Korean patients with acute hepatitis B.
Lee JH; Hong SP; Jang ES; Park SJ; Hwang SG; Kang SK; Jeong SH
J Med Virol; 2015 Jun; 87(6):993-8. PubMed ID: 25712861
[TBL] [Abstract][Full Text] [Related]
12. N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.
Lei YC; Tian YJ; Ding HH; Wang BJ; Yang Y; Hao YH; Zhao XP; Lu MJ; Gong FL; Yang DL
World J Gastroenterol; 2006 Dec; 12(46):7488-96. PubMed ID: 17167839
[TBL] [Abstract][Full Text] [Related]
13. A3G-induced mutations show a low prevalence and exhibit plus-strand regional distribution in hepatitis B virus DNA from patients with non-hepatocellular carcinoma (HCC) and HCC.
Ren F; Li W; Zhao S; Wang L; Wang Q; Li M; Xiang A; Guo Y
J Med Virol; 2021 Jun; 93(6):3672-3678. PubMed ID: 32779759
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of hepatocyte expression of hepatitis B viral core antigen and the clinicopathological characters in chronic hepatitis B patients].
Ding Y; Zou Z; Xu X; Zhao Z; Jia W; Fang Y; Li Y; Guo Y; Wang G
Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):185-9. PubMed ID: 24824119
[TBL] [Abstract][Full Text] [Related]
15. Influence of the basal core promoter and precore mutation on replication of hepatitis B virus and antiviral susceptibility of different genotypes.
Cui XJ; Cho YK; Song BC
J Med Virol; 2015 Apr; 87(4):601-8. PubMed ID: 25612255
[TBL] [Abstract][Full Text] [Related]
16. Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis B.
Lapalus M; Laouenan C; Cardoso AC; Estrabaud E; Carvalho-Filho RJ; Zhang Q; Lada O; Appourchaux K; Mouri F; Boyer N; Bedossa P; Asselah T; Martinot-Peignoux M; Marcellin P
Liver Int; 2015 Sep; 35(9):2082-9. PubMed ID: 25612083
[TBL] [Abstract][Full Text] [Related]
17. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication.
Bonvin M; Achermann F; Greeve I; Stroka D; Keogh A; Inderbitzin D; Candinas D; Sommer P; Wain-Hobson S; Vartanian JP; Greeve J
Hepatology; 2006 Jun; 43(6):1364-74. PubMed ID: 16729314
[TBL] [Abstract][Full Text] [Related]
18. Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.
Nair S; Zlotnick A
J Virol; 2018 May; 92(10):. PubMed ID: 29491156
[TBL] [Abstract][Full Text] [Related]
19. APOBEC3DE Antagonizes Hepatitis B Virus Restriction Factors APOBEC3F and APOBEC3G.
Bouzidi MS; Caval V; Suspène R; Hallez C; Pineau P; Wain-Hobson S; Vartanian JP
J Mol Biol; 2016 Aug; 428(17):3514-28. PubMed ID: 27289067
[TBL] [Abstract][Full Text] [Related]
20. Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G.
Nguyen DH; Gummuluru S; Hu J
J Virol; 2007 May; 81(9):4465-72. PubMed ID: 17314171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
